Suppr超能文献

利用针对H1和H2重链各自的特异性抗体开发一种用于检测人血浆α-胰蛋白酶抑制剂(ITI)的酶联免疫吸附测定法。

Development of an enzyme-linked immunosorbent assay for human plasma inter-alpha-trypsin inhibitor (ITI) using specific antibodies against each of the H1 and H2 heavy chains.

作者信息

Mizon C, Balduyck M, Albani D, Michalski C, Burnouf T, Mizon J

机构信息

Laboratoire de Biochimie, Faculte de Pharmacie, Lille, France.

出版信息

J Immunol Methods. 1996 Mar 28;190(1):61-70. doi: 10.1016/0022-1759(95)00257-x.

Abstract

Inter-alpha-trypsin inhibitor (ITI) is a serine-proteinase inhibitor of human plasma enzymes. ITI is composed of three polypeptide chains covalently linked: bikunin, responsible for the antiprotease activity and two heavy chains H1 and H2. Human plasma also contains other components immunologically related to ITI such as pre-alpha-trypsin inhibitor (paI), inter-alpha-like inhibitor (IalphaLI) and free bikunin. The ELISA procedure we propose exclusively measures native ITI within the range 12.5-200 microgram/l. The intra- and interassay coefficients of variation were less than 5.6% and 8.7%, respectively. When ITI was added to plasma samples, full recovery was obtained. EDTA-plasma from 30 healthy individuals revealed a mean level of 241.5 mg/l (range 145.5-506). The high specificity, sensitivity, reproducibility and accuracy of the present assay should facilitate the specific measurement of native ITI in blood and thus might represent a useful tool for further physiopathological studies.

摘要

α-胰蛋白酶抑制剂(ITI)是一种人血浆酶的丝氨酸蛋白酶抑制剂。ITI由三条共价连接的多肽链组成:负责抗蛋白酶活性的比库宁以及两条重链H1和H2。人血浆中还含有其他与ITI免疫相关的成分,如前α-胰蛋白酶抑制剂(paI)、α-样抑制剂(IalphaLI)和游离比库宁。我们提出的ELISA方法专门用于测定12.5 - 200微克/升范围内的天然ITI。批内和批间变异系数分别小于5.6%和8.7%。当向血浆样本中添加ITI时,可实现完全回收。30名健康个体的EDTA血浆显示平均水平为241.5毫克/升(范围145.5 - 506)。本检测方法的高特异性、敏感性、重现性和准确性应有助于血液中天然ITI的特异性测量,因此可能是进一步生理病理学研究的有用工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验